AI

biotech

Base to Base biotech podcast 76: Early disease detection and beating CNS cancers

Jim Cornall - September 18, 2026

biotech

‘Positive trends’ from phase 2 amyotrophic lateral sclerosis trial

Jim Cornall - September 17, 2026

biotech

Successful results from trial of first-in-class Parkinson’s disease peptide

Jim Cornall - September 17, 2026

biotech

Researchers uncover how neurons deliver RNA where it is needed

Jim Cornall - September 17, 2026

AI

A step towards AI-based precision medicine

Jim Cornall - October 16, 2023

AI

Business and artificial intelligence – how can we prepare for the ‘fourth’ industrial revolution?

admin - October 2, 2023

AI

FlowGPT Hackathon to focus on AI creativity and ethics

Jim Cornall - September 7, 2023

AI

Ibex raises $55m to drive global adoption of AI for cancer diagnosis

Jim Cornall - September 7, 2023

AI

How AI can help dentists with early detection of tooth decay

Jim Cornall - August 8, 2023

AI

AI-enhanced productivity in the workspace

Jim Cornall - August 7, 2023

AI

BioMap unveils Life Science Leaderboard to compare AI models

Jim Cornall - August 7, 2023

1...5 67Page 7 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 76: Early disease detection and beating CNS cancers

Jim Cornall - September 18, 2026 0

This week, we have conversations with Marc Hedrick, CEO of Cerenome, about a combined approach to tackling central nervous system (CNS) cancers, and Shaun...

‘Positive trends’ from phase 2 amyotrophic lateral sclerosis trial

biotech Jim Cornall - September 17, 2026 0

Successful results from trial of first-in-class Parkinson’s disease peptide

biotech Jim Cornall - September 17, 2026 0

Researchers uncover how neurons deliver RNA where it is needed

biotech Jim Cornall - September 17, 2026 0

Revvity to acquire Human Cell Design

biotech Jim Cornall - September 16, 2026 0